Insider Selling: Biodesix (NASDAQ:BDSX) CEO Sells 1,490 Shares of Stock

robot
Abstract generation in progress

Biodesix (NASDAQ:BDSX) CEO Scott Hutton recently sold 1,490 shares of the company’s stock for approximately $19,042, reducing his ownership by 2.96%. This transaction follows previous insider sales in February and January. Analysts currently rate Biodesix as a “Moderate Buy” with a consensus price target of $32.50, while institutional ownership stands at around 21%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)